CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse

Roni Tamari, Stephen S. Chung, Esperanza B. Papadopoulos, Ann A. Jakubowski, Patrick Hilden, Sean M. Devlin, Jenna D. Goldberg, Miguel Angel Perales, Doris M. Ponce, Craig S. Sauter, Molly A. Maloy, Dara Y. Herman, Virginia Klimek, James W. Young, Richard J. O'Reilly, Sergio A. Giralt, Hugo Castro-Malaspina

Research output: Contribution to journal › Article › peer-review

44 Scopus citations

Sort by
Weight
Alphabetically

CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse

Fingerprint

Medicine & Life Sciences